1. 1. Bo J-J, Zhang C, Zhang L-H, et al. Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks. Asian J Androl 13: 833-837, 2011.
2. 2. Braga-Basaria M, Dobs AS, Muller DC, et al. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol 24: 3979-3983, 2006.
3. 3. Gild P, Cole AP, Krasnova A, et al. Liver disease in men undergoing androgen deprivation therapy for prostate cancer. J Urol 200: 573-581, 2018.
4. 4. Wang H, Sun X, Zhao L, Chen X, Zhao J. Androgen deprivation therapy is associated with diabetes: evidence from meta-analysis. J Diabetes Investig 7: 629-636, 2016.
5. 5. Sun M, Choueiri TK, Hamnvik O-PR, et al. Comparison of gonadotropin-releasing hormone agonists and orchiectomy: effects of androgen-deprivation therapy. JAMA Oncol 2: 500-507, 2016.